| Not Yet Recruiting | Respiratory Microbioma and Respiratory Complications After Hematopoietic Stem Cell Transplantion NCT06639750 | University Hospital, Caen | — |
| Recruiting | Amimestrocel Injection for Preventing Severe Oral Mucositis in HSCT Patients NCT07400328 | The First Affiliated Hospital of Soochow University | Phase 2 |
| Recruiting | Zoledronate to Prevent Bone Health Complications in Pediatric Hematopoietic Stem Cell Transplant Survivors NCT07375290 | Children's Hospital Medical Center, Cincinnati | Phase 1 |
| Not Yet Recruiting | Integrating Vaccination Into Hospital Care Pathways for Vulnerable Patients NCT07391046 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Recruiting | Prevention of Graft Rejection in Hematopoietic Stem Cell Transplant (HSCT) Recipients NCT07244419 | Children's Hospital Medical Center, Cincinnati | EARLY_Phase 1 |
| Recruiting | Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation NCT07349498 | Peking University People's Hospital | — |
| Recruiting | Comparison of Etamsylate Versus Placebo to Prevent Bleeding in HSCT NCT07442513 | First Affiliated Hospital of Zhejiang University | Phase 3 |
| Not Yet Recruiting | HCMV-miRNA Monitoring After Allogeneic Hematopoietic Stem Cell Transplantation Using PSTM-qPCR NCT07210242 | Ting YANG | — |
| Completed | Physical Fitness of Allogeneic Stem Cell Transplant NCT07049536 | Istinye University | — |
| Not Yet Recruiting | Effect of a Simplified Mindfulness Intervention on Health-related Quality of Life in Patients Undergoing Hemat NCT07127562 | Institute of Hematology & Blood Diseases Hospital, China | N/A |
| Not Yet Recruiting | Remotely Monitored, Mobile Health-supported, High Intensity Interval Training Before Hematopoietic Stem Cell T NCT06953648 | University of Kansas Medical Center | N/A |
| Recruiting | Metagenomics Next-generation Sequencing Approach to Detect Microbial DNA/RNA Overtime in Individuals Undergoin NCT06904053 | National Institutes of Health Clinical Center (CC) | — |
| Recruiting | Tissue-resident Immune Cell Subsets in aGVHD NCT06708507 | Nanfang Hospital, Southern Medical University | — |
| Recruiting | Supportive Care Intervention for Outpatient Stem Cell Transplant Patients NCT06564233 | Victor Wang | N/A |
| Recruiting | Moxibustion in the Treatment of Hemorrhagic Cystitis After Allo-HSCT NCT06241274 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | N/A |
| Recruiting | Evaluation of CMV/EBV-CMI in Haploid HSCT NCT06554197 | The First Affiliated Hospital of Soochow University | — |
| Recruiting | Employment Support After Hematopoietic Stem Cell Transplantation NCT06494423 | MGH Institute of Health Professions | N/A |
| Not Yet Recruiting | Comparison of Different Dose of Anti-T Lymphocyte Globulin (ATLG) in Haploidentical HSCT for GVHD Prophylaxis NCT06525519 | Institute of Hematology & Blood Diseases Hospital, China | Phase 3 |
| Not Yet Recruiting | Prospective Observational Clinical Study on Changes in Cognitive Levels in Elderly Patients Before and After H NCT06484049 | Institute of Hematology & Blood Diseases Hospital, China | — |
| Recruiting | Prospective Clinical Trial for Children With TCRαβ Depleted vs Traditional Haplo Identicle HSCT NCT06423131 | Sijia Gu | N/A |
| Not Yet Recruiting | Efficacy and Safety of MTBF Conditioning Regimen for Salvageable Allo-HSCT in the Treatment of R/R AML NCT06385808 | First Affiliated Hospital Xi'an Jiaotong University | N/A |
| Recruiting | Moxibustion for the Prevention of Hemorrhagic Cystitis After Allo-HSCT NCT06198517 | Yi Zhang | N/A |
| Recruiting | αβT Cell/CD19+ B Cell Depletion for Alternative Donor Allogeneic Hematopoietic Cell Transplantation (HSCT) NCT06082947 | Nationwide Children's Hospital | N/A |
| Completed | Impact of Yoga and Gentle Massage Practices on Symptom Management in Patients Undergoing HSCT NCT06118853 | Hospital Israelita Albert Einstein | N/A |
| Recruiting | Identification of Plasma Biomarkers for Early Diagnosis of Transplant-associated Thrombotic Microangiopathy NCT06102694 | Institute of Hematology & Blood Diseases Hospital, China | — |
| Recruiting | TBI/Flu/Bu/Mel Combined With Secondary UCBT in Patients With Hematological Malignancies Who Relapsed After All NCT06125483 | The First Affiliated Hospital of Soochow University | N/A |
| Recruiting | Cultural Tailoring and Pilot Testing of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hemat NCT05681026 | M.D. Anderson Cancer Center | N/A |
| Recruiting | Brain Neuronal Networks, Chemosensory and Trigeminal Functions in Allo-HSCT NCT06003660 | University of Oslo | — |
| Enrolling By Invitation | Posaconazole Tablet As Primary Prophylaxis of HSCT Patients with Gastrointestinal GVHD NCT06698211 | Institute of Hematology & Blood Diseases Hospital, China | — |
| Recruiting | Low Power Laser Therapy As Prevention Of Oral Mucositis And Oropharyngeal Pain In Patients Undergoing Allogene NCT06071637 | Instituto Nacional de Cancer, Brazil | Phase 3 |
| Unknown | A Study to Evaluate the Safety and Efficacy of COVID-19 Convalescent Plasma (CCP) Transfusion to Prevent COVID NCT05904067 | Institute of Hematology & Blood Diseases Hospital, China | N/A |
| Recruiting | TFBC Combined With UCBT in the Treatment of High-risk Malignant Hematological Diseases NCT05929092 | The First Affiliated Hospital of Soochow University | N/A |
| Recruiting | Efficacy and Safety Study of Narsoplimab in Pediatric Patients With High-Risk Hematopoietic Stem Cell Transpla NCT05855083 | Omeros Corporation | Phase 2 |
| Completed | Letermovir Prophylaxis for CMV Infection in Haplo-HSCT Recipients: Single-center Data in China NCT05789615 | The First Affiliated Hospital of Soochow University | — |
| Unknown | A Multicenter Open-label Clinical Study on the Prevention of Premature Ovarian Failure After HSCT NCT05667428 | First Affiliated Hospital Xi'an Jiaotong University | N/A |
| Recruiting | A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme NCT05027945 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Developing a Exercise Program for Patients Undergoing Hematopoietic Stem Cell Transplantation NCT06907004 | Chimei Medical Center | — |
| Unknown | HCMV Breakthrough Infections During Letermovir Prophylaxis NCT06339892 | Fondazione IRCCS Policlinico San Matteo di Pavia | N/A |
| Completed | Oral Hygiene Management of Hematologic Patients Undergoing Auto-transplantation NCT06755333 | University of Pisa | — |
| Unknown | Immune Reconstitution to CMV After HSCT: Impact of Clinical Factors and Therapy Strategies NCT05656599 | Peking University People's Hospital | — |
| Unknown | The Impact of Donor COVID-19 Infection Status on the Recipient in Allo-HSCT NCT05675826 | Chen Suning | — |
| Unknown | Clinical Study of rATG Individualized Administration in Haploidentical Hematopoietic Stem Cell Transplantation NCT05634915 | The First Affiliated Hospital of Soochow University | Phase 4 |
| Recruiting | The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycopheno NCT05436418 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Recruiting | Longitudinal Early Advance Care Planning Discussions and Documentation (LEADD) Program: An Exploratory Study i NCT05605574 | National Cancer Institute (NCI) | N/A |
| Unknown | Venetoclax Plus RIC Regimen Allo-HSCT for Elderly Patients With High-risk Myeloid Malignancies NCT05583175 | Xianmin Song, MD | Phase 2 |
| Active Not Recruiting | Art and Physical Therapy in Pediatric HCT NCT05441670 | Medical University of South Carolina | N/A |
| Unknown | Evaluation of the Impact of the Use of NewSpringForMe on Transplanted Patients' Quality of Life and Support NCT06148610 | Fonds de Dotation HTC Project | — |
| Recruiting | Inotuzumab Ozogamicin in the Treatment of MRD+ After HSCT of ALL NCT05940961 | Sheng-Li Xue, MD | Phase 2 |
| Unknown | Letermovir for the Prevention of CMV Infection in HSCT Recipients Based on the Outcome of mNGS NCT06021210 | The First Affiliated Hospital of Soochow University | Phase 2 |
| Unknown | Venetoclax and Decitabin Based Conditioning Regimen Followed With Post-HSCT Decitabin Maintenance Therapy in T NCT05528354 | Zhejiang University | EARLY_Phase 1 |
| Unknown | The Association of Microbiota Composition With cGVHD After Allo-HSCT NCT05355675 | First Affiliated Hospital of Zhejiang University | — |
| Completed | Infliximab Efficacy, TDM and Serum TNFα Levels in Pediatric HSCT Recipients With aGVHD: Prospective Observatio NCT05362630 | University of Pisa | — |
| Completed | Haplo-PBSC+Cord vs Haplo-PBSC+BM for Hematological Malignancies Undergoing Allo-HSCT NCT05290545 | Nanfang Hospital, Southern Medical University | Phase 3 |
| Completed | Myths and Misconceptions About HSCT in a Limited Resource Region NCT05151406 | Assiut University | N/A |
| Enrolling By Invitation | Prophylactic Entecavir for HBV Reactivation in Past HBV Infected Patients With Hematopoietic Stem Cell Transpl NCT04942886 | Seoul St. Mary's Hospital | N/A |
| Unknown | Early Identification and Evaluation of Cyclophosphamide Cardiotoxicity NCT05150080 | Kai Mu | — |
| Unknown | Precision Dosing of Busulfan in Children Undergoing HSCT NCT04822532 | University Hospital, Geneva | N/A |
| Unknown | Pharmacokinetic Study of Post-transplant Cyclophosphamide in Pediatric Patients NCT04945954 | Seoul National University Hospital | N/A |
| Active Not Recruiting | Immunomonitoring After Hematopoietic Stem Cell Transplantation NCT04635397 | Centre Hospitalier Universitaire de Nice | — |
| Completed | Effects of Music Therapy in Controlling Symptoms in Patients With AML and Undergoing HSCT NCT05696457 | Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | N/A |
| Terminated | Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft Versus Host Disease (GVHD) Following Myelo NCT04095858 | Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Phase 3 |
| Unknown | Sorafenib Maintenance for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3 Negative Acute Leu NCT04674345 | Nanfang Hospital, Southern Medical University | Phase 2 / Phase 3 |
| Unknown | Target Busulfan Exposure in Children With HSCT in China NCT04786002 | The First Affiliated Hospital of Soochow University | — |
| Unknown | Pharmacokinetics and Pharmacodynamics of Mycophenolate Mofetil in Pediatric Hematopoietic Stem Cell Transplant NCT04868786 | Seoul National University Hospital | Phase 1 |
| Recruiting | Effects of Mesenchymal Stem Cell Supernatant on Prevention and Treatment of Skin/Mucosal Injury in Hematology NCT06599346 | The General Hospital of Western Theater Command | N/A |
| Completed | AntiCMV molécules Monitoring in Real-life in Stem Cell Recipients NCT04690933 | University Hospital, Limoges | — |
| Unknown | Pharmacokinetic Study of Melphalan in Pediatric Hematopoietic Stem Cell Transplantation NCT04937634 | Seoul National University Hospital | Phase 1 |
| Enrolling By Invitation | A Study to Assess CSF1R-related Leukoencephalopathy After Stem Cell Transplantation NCT04503213 | Mayo Clinic | — |
| Withdrawn | Biospecimen Procurement for Immunological Landscape Studies Following Hematopoietic Cell Transplantation NCT04428918 | National Cancer Institute (NCI) | — |
| Unknown | Effect of the Cycloergometer in Patients Undergoing Hematopoietic Stem Cell Transplantation NCT04496011 | Federal University of Health Science of Porto Alegre | N/A |
| Completed | The Effects of Heart Rate Variability Biofeedback Training on Hematopoietic Cell Transplantation Patients NCT04275830 | Arizona State University | N/A |
| Unknown | The Molecular Mechanism of CMV-driven NKG2C+NK Cell Expansion in Human NCT04298502 | Peking University People's Hospital | — |
| Completed | Protocol For Collecting Long-Term Follow-Up Data On Recipients of Bone Marrow and Blood Stem Cell Transplant NCT00674882 | St. Jude Children's Research Hospital | — |
| Unknown | Effect of Angiotensin Converting Enzyme and Sacubitril Valsartan in Patients After Bone Marrow Transplantation NCT04092309 | University of Athens | N/A |
| Unknown | ATG in HLA-matched Sibling HSCT as GVHD Prophylaxis NCT04203108 | Nanfang Hospital, Southern Medical University | Phase 4 |
| Completed | Zoledronic Acid in Combination With Interleukin-2 to Expand Vγ9Vδ2 T Cells After T-replete Haplo-identical All NCT03862833 | Nantes University Hospital | Phase 1 |
| Completed | Multimodal Sexual Dysfunction Intervention In HCT NCT03803696 | Massachusetts General Hospital | N/A |
| Unknown | Dysbiosis and Immune Reconstitution After Allo-HSCT NCT03616015 | Central Hospital, Nancy, France | N/A |
| Unknown | PTCy-ATG vs ATG in Haploidentical HSCT for Acute Graft-versus-host Disease Prophylaxis NCT03689465 | Nanfang Hospital, Southern Medical University | Phase 4 |
| Recruiting | Nutritional Status of Patients After Hematopoietic Stem Cell Transplantation NCT04146870 | The First Affiliated Hospital of Soochow University | — |
| Completed | Evolution of the Energy Expenditure During Hematopoietic Stem Cell Transplantation NCT04535570 | Federal University of Minas Gerais | — |
| Completed | Mesenchymal Stem Cells for the Treatment of Pneumonia Post Haematopoietic Stem Cell Transplantation NCT05131412 | Guangzhou Women and Children's Medical Center | — |
| Completed | Eltrombopag vs. rhTPO to Increase Platelet Level After HSCT NCT03515096 | Shenzhen Second People's Hospital | Phase 3 |
| Completed | Characteristics and Dynamics of TCR Repertoire in Patients With Hematological Malignancies After Allo-HSCT NCT03575767 | Affiliated Hospital to Academy of Military Medical Sciences | — |
| Completed | Effects of Pulmonary Rehabilitation in Hematopoietic Stem Cell Transplantation Recipients NCT03625063 | Gazi University | N/A |
| Completed | Optimization of Antibiotic Treatment in Hematopoietic Stem Cell Receptors NCT03727113 | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | — |
| Completed | High Dose Intravenous Thiamine for the Prevention of Delirium in Allogeneic Hematopoietic Stem Cell Transplant NCT03263442 | UNC Lineberger Comprehensive Cancer Center | Phase 2 |
| Completed | Effects of Digital Stories Intervention on Psychosocial Well-being NCT03654599 | Arizona State University | N/A |
| Withdrawn | Ledipasvir/Sofosbuvir Treatment for Hepatitis C in HCT Recipients. NCT03279133 | Kaiser Permanente | Phase 4 |
| Completed | Haplo HCT vs Haplo-cord HCT for Patients With AML NCT03719534 | The First Affiliated Hospital of Soochow University | Phase 3 |
| Active Not Recruiting | Ixazomib in the Prophylaxis of Chronic Graft-versus-host Disease. NCT03225417 | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | Phase 1 / Phase 2 |
| Completed | Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients NCT02763033 | University of Michigan Rogel Cancer Center | Phase 2 |
| Recruiting | Long-Term Follow-up of People Undergoing Hematopoietic Stem Cell Transplantation NCT03000244 | National Cancer Institute (NCI) | — |
| Completed | Evaluation of Malglycemia Via Continuous Glucose Monitoring in the Pediatric HSCT Population NCT03037671 | University of Colorado, Denver | — |
| Unknown | Erythropoietin in the Treatment of Anemia After Autologous Hematopoietic Stem Cell Transplantation NCT03010579 | Peking University | Phase 4 |
| Completed | Phase II Trial of Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft-Versus-Host Disease (GVH NCT02663622 | Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Phase 2 |
| Completed | Nutrition Intervention Among Stem Cell Recipients: Post Hospital Discharge NCT02791347 | American University of Beirut Medical Center | N/A |
| Completed | Safety and Tolerability of Intravenous Fish Oil Lipid Emulsion in Children Undergoing Hematopoietic Cell Trans NCT02512718 | Alexandra N. Carey | Phase 1 |
| Unknown | Recombinant Human Thrombopoietin for Mobilization of Peripheral Blood Progenitor Cells for Autologous Transpla NCT03014102 | Hongnan Mo | Phase 1 / Phase 2 |
| Unknown | A Trial of Plerixafor/G-CSF as Additional Agents for Conditioning Before TCR Alpha/Beta Depleted HSCT in WAS P NCT03019809 | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | Phase 2 |
| Completed | Physical Activity in Children During Hematopoietic Stem Cells Transplantation (HSCT) NCT03842735 | A.O.U. Città della Salute e della Scienza | N/A |
| Completed | The "Light for the Brain" Study NCT02677987 | Northwestern University | N/A |
| Completed | Effects of Upper Extremity Aerobic Exercise Training in Hematopoietic Stem Cell Transplantation Recipients NCT03007602 | Gazi University | N/A |
| Completed | Sitagliptin for Prevention of Acute Graft Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transpl NCT02683525 | Sherif S. Farag | Phase 2 |
| Completed | MRD-directed Donor Lymphocyte Infusion for Reduce of Relapse After Allo-HSCT NCT02673008 | Nanfang Hospital, Southern Medical University | Phase 2 / Phase 3 |
| Unknown | Body Composition Changes During Stem Cell Transplantation: The Case Of Lymphoma Patients NCT02983643 | American University of Beirut Medical Center | — |
| Completed | Fitness in Allogeneic Stem Cell Transplantation NCT02564458 | UNC Lineberger Comprehensive Cancer Center | N/A |
| Completed | Pilot Study Using Propranolol To Promote Prenylation Of Gtpase Rap1b In Hematopoietic Stem Cell Transplant Rec NCT02535182 | Medical College of Wisconsin | — |
| Completed | Sorafenib for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3-ITD Positive AML NCT02474290 | Nanfang Hospital, Southern Medical University | Phase 2 / Phase 3 |
| Completed | TRial to EvaluAte Tranexamic Acid Therapy in Thrombocytopenia NCT03136445 | NHS Blood and Transplant | Phase 3 |
| Completed | A Pharmacokinetic Study of Melphalan in Children NCT02390544 | Children's Hospital Medical Center, Cincinnati | Phase 1 |
| Completed | Comparison of Gut Microbiota, Inflammation and Symptoms Following Allogeneic HSCT NCT02398708 | University of Florida | — |
| Completed | Study for the Evaluation of a GVHD Negative Outcome Score (GNOS) in Matched Unrelated or Haploidentical Hemato NCT02414113 | Washington University School of Medicine | — |
| Terminated | Cryotherapy in the Prevention of Chemotherapy-Induced Mucositis in Stem Cell Transplant NCT02326675 | University of Florida | N/A |
| Completed | Post-transplantation Cyclophosphamide for Haploidentical Transplant From Maternal or Collateral Donors NCT02412423 | Peking University People's Hospital | Phase 4 |
| Completed | A Study of Tacrolimus/Methotrexate and Tocilizumab to Prevent Acute Graft-Versus-Host Disease (AGVD) After All NCT02206035 | William R. Drobyski, MD | Phase 2 |
| Enrolling By Invitation | Belgian Cross-sectional Allogeneic Transplant Survivor Study NCT02312830 | Universitaire Ziekenhuizen KU Leuven | — |
| Completed | Theraworx Bath Wipes Versus Standard Bath Wipes in the Reduction of Vancomycin-Resistant Enterococci NCT02241005 | St. Jude Children's Research Hospital | N/A |
| Completed | Mesenchymal Stem Cell Infusion in Haploidentical Hematopoietic Stem Cell Transplantation in Patients With Hema NCT03106662 | Ankara University | Phase 3 |
| Active Not Recruiting | Standardization of CD3+ T Cell Dose for Patients Receiving Allogeneic Peripheral Blood Stem Cell Transplantati NCT00959140 | University of Alabama at Birmingham | N/A |
| Unknown | MSC for Treatment of Interstitial Lung Disease After Allo-HSCT NCT02543073 | Nanfang Hospital, Southern Medical University | Phase 1 / Phase 2 |
| Unknown | Toward Immune Biomarkers for Tolerance and GvHD in Humans NCT02319226 | Assistance Publique - Hôpitaux de Paris | — |
| Unknown | Maraviroc-Based GVHD Prophylaxis in HLA-Unrelated and HLA-Mismatched Related Transplantation NCT02799888 | Affiliated Hospital to Academy of Military Medical Sciences | Phase 2 |
| Completed | Hepatosplenic CANdidiasis : PETscan and Immune Response Analysis NCT01916057 | Assistance Publique - Hôpitaux de Paris | N/A |
| Completed | ATG in Haploidentical HSCT for Acute Graft-versus-host Disease Prophylaxis NCT01883180 | Nanfang Hospital, Southern Medical University | Phase 4 |
| Unknown | Dose Study of Antithymocyteglobulin in Haploidentical Allogeneic Stem Cell Transplantation NCT02643589 | Nanfang Hospital, Southern Medical University | N/A |
| Unknown | Mesenchymal Stem Cells Combined With Cord Blood for Treatment of Graft Failure NCT01763099 | Nanfang Hospital, Southern Medical University | Phase 2 |
| Completed | Piperacillin/Tazobactam for Empirical Therapy of Febrile Neutropenia NCT01714570 | Chinese PLA General Hospital | N/A |
| Completed | Intrabone Infusion of Umbilical Cord Blood Stem Cells NCT01711788 | Henrique Bittencourt, MD, PhD | Phase 2 |
| Unknown | Prophylactic Piperacillin/Tazobactam in Hematopoietic Stem Cell Transplantation NCT01714557 | Chinese PLA General Hospital | N/A |
| Completed | TCR Alpha/Beta Depletion for HSCT From Haploidentical and Unrelated Donors in the Treatment of PID NCT02327351 | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | Phase 2 / Phase 3 |
| Completed | Effectiveness Rehabilitation Hematopoietic Transplantation (ovERsHOT) NCT03324620 | Hospital Clinic of Barcelona | N/A |
| Completed | Cyclosporine (CSA) Level in Blood Samples Collected From Different Lines NCT01598688 | University of Sao Paulo | N/A |
| Completed | Physical Inactivity in Candidates of HSCT NCT03915210 | Gazi University | — |
| Completed | Influence of Co-existing Mutations on Sorafenib Maintenance Therapy After Allo-HSCT for Patients With FLT3-ITD NCT04788420 | Nanfang Hospital, Southern Medical University | — |
| Completed | Treating Cancer-Related Fatigue Through Systematic Light Exposure NCT01873794 | Icahn School of Medicine at Mount Sinai | N/A |
| Completed | Immunomodulatory Effect of Vitamin D in Allogenic Post-transplant NCT02600988 | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | Phase 1 / Phase 2 |
| Completed | Feasibility of Collecting Quality of Life Data in Collaboration With the Stem Cell Therapeutic Outcomes Databa NCT01353677 | Center for International Blood and Marrow Transplant Research | — |
| Unknown | Oral Selenium Therapy for the Prevention of Mucositis NCT01432873 | Tehran University of Medical Sciences | Phase 1 / Phase 2 |
| Unknown | Hematopoietic Stem Cell Transplantation With Targeted Busulfan and Fludarabine in Pediatric AML NCT01274195 | Seoul National University Hospital | Phase 2 |
| Completed | Respiratory Impedance and Obliterative Bronchiolitis NCT01255449 | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy | N/A |
| Completed | NOX-A12 Multiple Ascending Dose Study in Healthy Volunteers NCT01194934 | TME Pharma AG | Phase 1 |
| Unknown | Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplant NCT01135589 | Asan Medical Center | Phase 4 |
| Completed | Maraviroc in Patients Undergoing Non-Myeloablative Allogeneic Stem-Cell Transplantation NCT00948753 | Abramson Cancer Center at Penn Medicine | Phase 1 / Phase 2 |
| Completed | Hematopoietic Stem Cell Transplantation Based on Pharmacokinetic and Pharmacodynamic Modeling NCT01018446 | Seoul National University Hospital | Phase 1 |
| Completed | Iron Overload in Patients Undergoing Donor Stem Cell Transplant NCT00888316 | Masonic Cancer Center, University of Minnesota | — |
| Completed | Problem-Solving Education for Caregivers and Patients During Stem Cell Transplant NCT00766883 | National Institutes of Health Clinical Center (CC) | Phase 2 |
| Completed | Dose Escalation Study Of Palifermin in Pediatric Research Participants Undergoing Allogeneic Hematopoietic Ste NCT00701688 | St. Jude Children's Research Hospital | Phase 1 |
| Unknown | Evaluate Three Methods for Diagnosis of Invasive Fungal Infection in Chinese Patients After HSCT NCT00460330 | Peking University | — |
| Terminated | Glucose Control In Hematopoetic Stem Cell Transplant NCT00582036 | University of Oklahoma | N/A |
| Withdrawn | In-Vitro Studies in Depletion of Haplotype Mismatched Alloreactive T Cells NCT00731705 | Indiana University School of Medicine | — |
| Completed | Spouses/Partners Expressing Their Thoughts After Transplant NCT01061801 | Fred Hutchinson Cancer Center | N/A |
| Completed | Safety of a Single Dose of 5 mg of hLF1-11 Given to Autologous Haematopoietic Stem Cell Transplant Recipients NCT00509938 | AM-Pharma | Phase 1 / Phase 2 |
| Recruiting | The Collection and Storage of Umbilical Cord Blood for Transplantation NCT01728545 | M.D. Anderson Cancer Center | — |
| Completed | Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Malignant Hematological Diseases NCT00582894 | University of Oklahoma | N/A |
| Completed | Ambulatory Physical Exercise Program in Hematopoietic Stem Cell Transplantation Recipients NCT00402753 | University of Zurich | EARLY_Phase 1 |
| Unknown | Basiliximab for the Treatment of Acute Graft-versus-host Disease After Allogeneic Stem Cell Transplantation NCT00563108 | Hospital Authority, Hong Kong | N/A |
| Completed | A Study of Caspofungin, Liposomal Amphotericin B or the Combination of Both for Patients After Stem-Cell Trans NCT00148148 | University Hospital Muenster | Phase 2 |
| Completed | Cyclosporine Dose Adjustment According to Calcineurin Activity After Allogeneic Hematopoietic Stem-cell Transp NCT00948727 | Assistance Publique - Hôpitaux de Paris | Phase 2 |
| Completed | Nutrition Support in Pediatric Stem Cell Transplantation NCT00115258 | Boston Children's Hospital | Phase 3 |
| Unknown | Mycophenolate Mofetil for the Prophylaxis of Graft-versus-host Disease in High Risk Allogeneic Stem Cell Trans NCT00563589 | Hospital Authority, Hong Kong | N/A |
| Completed | Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant NCT00179049 | Vanderbilt University | — |
| Completed | Repository: Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant NCT00179075 | Vanderbilt University | — |
| Completed | A Safety Evaluation of Drotrecogin Alfa (Activated) in Patients With Blood Cancer, Severe Infection Related to NCT00067730 | Eli Lilly and Company | Phase 4 |
| Completed | Blood and Marrow Transplant Clinical Research Network NCT00023530 | National Heart, Lung, and Blood Institute (NHLBI) | N/A |
| Completed | Induction of Stable Chimerism for Sickle Cell Anemia NCT00029393 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 |
| Completed | Lymphocyte Count, ATG Dose and Incidence and Severity of GVHD in Pediatric Recipients of HSCT NCT04869254 | IRCCS Burlo Garofolo | — |
| Completed | Gender Differences in Pediatric Hematopoietic Stem Cell Transplantation (HSCT) NCT04580576 | IRCCS Burlo Garofolo | — |
| Completed | Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia NCT00029380 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 |
| Completed | Cord Blood Stem Cell Transplantation Study (COBLT) NCT00000603 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 |